India Rumored To Be Considering Price-Control Relief For Small Pharmas
This article was originally published in PharmAsia News
Executive Summary
About 5,000 small pharmaceutical companies could be freed of price controls under a plan being considered by India's government. The companies are ones located outside excise-free zones that have sales of $2.4 million or less. Authorities are believed to be considering such a move to relieve companies hit by the introduction of maximum retail prices at a time the prices of raw materials imported from China are rising. One senior government official denied, however, there was any move to exempt small pharmas from price controls. (Click here for more